AngioDynamics(ANGO) - 2025 Q2 - Quarterly Results

Exhibit 99.1 AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results LATHAM, N.Y.--(BUSINESS WIRE)— Jan 8, 2025-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the second quarter of fiscal year 2025, which ended November 30, 2024. Fiscal Year 2025 Second Quarte ...